Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Parker, J. Parker (1998)
Nitrate therapy in stable angina pectoris.The New England journal of medicine, 318 2
G. Simonneau, R. Barst, N. Galiè, R. Naeije, S. Rich, R. Bourge, A. Keogh, R. Oudiz, A. Frost, S. Blackburn, J. Crow, L. Rubin (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.American journal of respiratory and critical care medicine, 165 6
M. Wilkins, G. Paul, J. Strange, N. Tunariu, W. Gin-Sing, W. Banya, M. Westwood, A. Stefanidis, L. Ng, D. Pennell, R. Mohiaddin, P. Nihoyannopoulos, J. Gibbs (2005)
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.American journal of respiratory and critical care medicine, 171 11
David Webb, Stephen Freestone, Michael Allen, Gary Muirhead (1999)
Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.The American journal of cardiology, 83 5A
J. Deanfield, J. Halcox, T. Rabelink (2007)
Endothelial function and dysfunction: testing and clinical relevance.Circulation, 115 10
C. Opitz, R. Wensel, J. Winkler, M. Halank, L. Bruch, F. Kleber, G. Höffken, S. Anker, A. Negassa, S. Felix, R. Hetzer, R. Ewert (2005)
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.European heart journal, 26 18
J. Halcox, K. Nour, G. Zalos, R. Mincemoyer, M. Waclawiw, Candido Rivera, Georgia Willie, S. Ellahham, A. Quyyumi (2002)
The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.Journal of the American College of Cardiology, 40 7
E. Takimoto, H. Champion, Manxiang Li, Diego Belardi, S. Ren, E. Rodriguez, D. Bedja, K. Gabrielson, Yibin Wang, D. Kass (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophyNature Medicine, 11
B. Rosengarten, R. Schermuly, R. Voswinckel, M. Kohstall, H. Olschewski, N. Weissmann, W. Seeger, Manfred Kaps, F. Grimminger, H. Ghofrani (2006)
Sildenafil Improves Dynamic Vascular Function in the Brain: Studies in Patients with Pulmonary HypertensionCerebrovascular Diseases, 21
V. Mclaughlin (2006)
Survival in patients with pulmonary arterial hypertension treated with first‐line bosentanEuropean Journal of Clinical Investigation, 36
O. Ali, J. Wharton, J. Gibbs, L. Howard, M. Wilkins (2007)
Emerging therapies for pulmonary arterial hypertensionExpert Opinion on Investigational Drugs, 16
N. Galiè, M. Humbert, J. Vachiéry, C. Vizza, M. Kneussl, A. Manes, O. Sitbon, A. Torbicki, M. Delcroix, R. Naeije, M. Hoeper, A. Chaouat, S. Morand, B. Besse, G. Simonneau (2002)
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.Journal of the American College of Cardiology, 39 9
S. Miyamoto, N. Nagaya, T. Satoh, S. Kyotani, F. Sakamaki, M. Fujita, N. Nakanishi, K. Miyatake (2000)
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.American journal of respiratory and critical care medicine, 161 2 Pt 1
G. D'Alonzo, R. Barst, S. Ayres, E. Bergofsky, B. Brundage, K. Detre, A. Fishman, R. Goldring, B. Groves, J. Kernis, P. Levy, G. Pietra, L. Reid, J. Reeves, S. Rich, C. Vreim, George Williams, Margaret Wu (1991)
Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective RegistryAnnals of Internal Medicine, 115
D. Walker, M. Ackland, G. James, G. Muirhead, D. Rance, P. Wastall, P. Wright (1999)
Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man.Xenobiotica; the fate of foreign compounds in biological systems, 29 3
Fernando Torres (2007)
Systematic review of randomised, double‐blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertensionInternational Journal of Clinical Practice, 61
A. Mahmud, M. Hennessy, J. Feely (2001)
Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive menJournal of Human Hypertension, 15
L. Ignarro, P. Bush, G. Buga, K. Wood, J. Fukuto, J. Rajfer (1990)
Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.Biochemical and biophysical research communications, 170 2
R. Channick, G. Simonneau, O. Sitbon, I. Robbins, A. Frost, V. Tapson, D. Badesch, S. Roux, M. Rainisio, F. Bodin, L. Rubin (2001)
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 358
Stuart Katz, Kujtim Balidemaj, Shunichi Homma, Henry Wu, Jie Wang, Simon Maybaum (2000)
Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure.Journal of the American College of Cardiology, 36 3
D.B. Badesch, V.F. Tapson, M.D. McGoon (2000)
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trialAnn Intern Med, 132
O. Sitbon, M. Humbert, X. Jaïs, V. Ioos, A. Hamid, S. Provencher, Gilles Garcia, F. Parent, P. Hervé, G. Simonneau (2005)
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial HypertensionCirculation, 111
Kimberly Lucas, G. Pitari, G. Pitari, S. Kazerounian, I. Ruiz-Stewart, Jason Park, S. Schulz, K. Chepenik, S. Waldman (2000)
Guanylyl cyclases and signaling by cyclic GMP.Pharmacological reviews, 52 3
Lei Wang, Zhenggang Zhang, R. Zhang, M. Chopp (2005)
Activation of the PI3-K/Akt Pathway Mediates cGMP Enhanced-Neurogenesis in the Adult Progenitor Cells Derived from the Subventricular ZoneJournal of Cerebral Blood Flow & Metabolism, 25
L. Rubin, D. Badesch, R. Barst, N. Galiè, C. Black, A. Keogh, T. Pulido, A. Frost, S. Roux, I. Leconte, M. Landzberg, G. Simonneau (2002)
Bosentan therapy for pulmonary arterial hypertension.The New England journal of medicine, 346 12
M. Hoeper, M. Schwarze, Stefan Ehlerding, A. Adler-Schuermeyer, E. Spiekerkoetter, J. Niedermeyer, M. Hamm, Helmut Fabel (2000)
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.The New England journal of medicine, 342 25
A. Atz, D. Wessel (1999)
Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.Anesthesiology, 91 1
G. Simonneau, N. Galiè, Lewis Rubin, D. Langleben, W. Seeger, G. Domenighetti, S. Gibbs, D. Lebrec, R. Speich, M. Beghetti, S. Rich, A. Fishman (2004)
Clinical classification of pulmonary hypertension.Journal of the American College of Cardiology, 43 12 Suppl S
V. McLaughlin, D. Badesch, S. Abman, G. Simonneau, L. Rubin (2007)
Evidence-Based Clinical Practice Guidelines Hypertension: Updated ACCP Medical Therapy for Pulmonary Arterial
R. Tuder, C. Cool, M. Geraci, Jun Wang, S. Abman, Laurel Wright, D. Badesch, N. Voelkel (1999)
Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.American journal of respiratory and critical care medicine, 159 6
R. Fries, K. Shariat, H. Wilmowsky, M. Böhm (2005)
Sildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory TherapyCirculation, 112
M. McGoon, D. Gutterman, V. Steen, R. Barst, D. Mccrory, T. Fortin, J. Loyd (2004)
Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.Chest, 126 1 Suppl
H. Olschewski, G. Simonneau, N. Galiè, T. Higenbottam, R. Naeije, Lewis Rubin, S. Nikkho, R. Speich, M. Hoeper, J. Behr, J. Winkler, O. Sitbon, W. Popov, H. Ghofrani, A. Manes, D. Kiely, R. Ewert, A. Meyer, P. Corris, M. Delcroix, M. Gómez-Sánchez, H. Siedentop, W. Seeger (2002)
Inhaled iloprost for severe pulmonary hypertension.The New England journal of medicine, 347 5
H. Arai, S. Hori, I. Aramori, H. Ohkubo, S. Nakanishi (1990)
Cloning and expression of a cDNA encoding an endothelin receptorNature, 348
S. Rosenkranz, F. Diet, T. Karasch, J. Weihrauch, K. Wassermann, E. Erdmann (2003)
Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon.Annals of internal medicine, 139 10
RuiLan Zhang, Ying Wang, Li Zhang, Z. Zhang, W. Tsang, Mei Lu, Lijie Zhang, M. Chopp (2002)
Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in RatsStroke: Journal of the American Heart Association, 33
F. Montorsi, T.E.D McDermott, Robert Morgan, Arne Olsson, Alexander Schultz, H. Kirkeby, Ian Osterloh (1999)
Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies.Urology, 53 5
L. Rubin, D. Badesch (2005)
Evaluation and Management of the Patient with Pulmonary Arterial HypertensionAnnals of Internal Medicine, 143
J. Ziegler, D. Ivy, JAMES W. Wiggins, J. Kinsella, William Clarke, S. Abman (1998)
Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.American journal of respiratory and critical care medicine, 158 5 Pt 1
AM Olsson, C‐A Persson (2001)
EFFICACY AND SAFETY OF SILDENAFIL CITRATE FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH CARDIOVASCULAR DISEASEInternational Journal of Clinical Practice, 55
R.J. Barst, L.J. Rubin, W.A. Long (1996)
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study GroupN Engl J Med, 334
R. Barst, M. McGoon, V. McLaughlin, V. Tapson, S. Rich, L. Rubin, K. Wasserman, R. Oudiz, S. Shapiro, I. Robbins, R. Channick, D. Badesch, B. Rayburn, Robert Flinchbaugh, J. Sigman, C. Arneson, R. Jeffs (2003)
Beraprost therapy for pulmonary arterial hypertension.Journal of the American College of Cardiology, 41 12
T. Sakurai, M. Yanagisawa, Yoh Takuwat, Httoshi Miyazakit, S. Kimura, K. Goto, T. Masaki (1990)
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 348
S. Prasad, J. Wilkinson, M. Gatzoulis (2000)
Sildenafil in primary pulmonary hypertension.The New England journal of medicine, 343 18
R. Benza, S. Mehta, A. Keogh, E. Lawrence, R. Oudiz, R. Barst (2007)
Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 26 1
D. Langleben, D. Badesch, A. Frost, Clinton Lawrence, S. Shapiro, R. Naeije, azzareno Galié (2006)
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.Journal of the American College of Cardiology, 47 10
L. Rubin (1988)
Primary Pulmonary HypertensionDrugs, 43
A. Giaid, M. Yanagisawa, D. Langleben, R. Michel, R. Levy, H. Shennib, S. Kimura, Tomoh Masaki, William Duguid, D. Stewart (1993)
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.The New England journal of medicine, 328 24
D. Badesch, S. Abman, G. Ahearn, R. Barst, D. Mccrory, G. Simonneau, V. McLaughlin (2004)
Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice GuidelinesChest, 126
D. Stewart, R. Levy, P. Cernacek, D. Langleben (1991)
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?Annals of internal medicine, 114 6
B. Stuckey, M. Jadzinsky, L. Murphy, F. Montorsi, A. Kadıoğlu, F. Fraige, P. Manzano, C. Deerochanawong (2003)
Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial.Diabetes care, 26 2
Jocelyn Dupuis, Duncan Stewart, P. Cernacek, Gilbert Gosselin (1996)
Human pulmonary circulation is an important site for both clearance and production of endothelin-1.Circulation, 94 7
Lewis Rubin, J. Mendoza, Michele Hood, M. McGoon, R. Barst, W. Williams, J. Diehl, J. Crow, W. Long (1990)
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized TrialAnnals of Internal Medicine, 112
S. Moncada, R. Palmer, E. Higgs (1991)
Nitric oxide: physiology, pathophysiology, and pharmacology.Pharmacological reviews, 43 2
D. Badesch, V. McLaughlin, M. Delcroix, C. Vizza, H. Olschewski, O. Sitbon, R. Barst (2004)
Prostanoid therapy for pulmonary arterial hypertension.Journal of the American College of Cardiology, 43 12 Suppl S
H. Ghofrani, I. Osterloh, F. Grimminger (2006)
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyondNature Reviews. Drug Discovery, 5
H. Ghofrani, R. Voswinckel, F. Reichenberger, H. Olschewski, Peter Haredza, B. Karadaş, R. Schermuly, N. Weissmann, W. Seeger, F. Grimminger (2004)
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.Journal of the American College of Cardiology, 44 7
N. Galiè, H. Ghofrani, A. Torbicki, R. Barst, L. Rubin, D. Badesch, T. Fleming, T. Parpia, G. Burgess, A. Branzi, F. Grimminger, M. Kurzyna, G. Simonneau (2005)
Sildenafil citrate therapy for pulmonary arterial hypertension.The New England journal of medicine, 353 20
D. Badesch, V. Tapson, M. McGoon, B. Brundage, L. Rubin, F. Wigley, S. Rich, R. Barst, P. Barrett, K. Kral, Maria Jbsis, J. Loyd, S. Murali, A. Frost, R. Girgis, R. Bourge, D. Ralph, C. Elliott, N. Hill, D. Langleben, R. Schilz, V. McLaughlin, I. Robbins, B. Groves, S. Shapiro, T. Medsger, S. Gaine, E. Horn, J. Decker, K. Knobil (2000)
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of DiseaseAnnals of Internal Medicine, 132
P. McDonnell, Patryce Toye, G. Hutchins (2015)
Primary pulmonary hypertension and cirrhosis: are they related?The American review of respiratory disease, 127 4
A. Evans, H. Cobban, G. Nixon (1999)
ETA receptors are the primary mediators of myofilament calcium sensitization induced by ET‐1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathwayBritish Journal of Pharmacology, 127
E. Romberg (1881)
Uebere sklerose der lungenarterienDtsch Arch Klin Med, 48
R. Barst, Lewis Rubin, W. Long, M. McGoon, S. Rich, D. Badesch, B. Groves, V. Tapson, R. Bourge, B. Brundage, S. Koerner, D. Langleben, C. Keller, S. Murali, B. Uretsky, L. Clayton, M. Jöbsis, S. Blackburn, Denise Shortino, J. Crow (1996)
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.The New England journal of medicine, 334 5
J. Corbin, A. Beasley, Mitsi Blount, S. Francis (2005)
High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors.Biochemical and biophysical research communications, 334 3
S. Rich, D. Dantzker, S. Ayres, E. Bergofsky, B. Brundage, K. Detre, A. Fishman, R. Goldring, B. Groves, S. Koerner (1987)
PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDYAnnals of Internal Medicine, 107
Phosphodiesterases (PDEs) are important components in cellular signaling in many vascular beds. Although the most recognized PDE inhibitor, sildenafil, a specific PDE5 inhibitor, is best known for its effect on the penile vascular bed resulting in erection, it also has therapeutic effects in other vascular beds, including the coronary and pulmonary vasculature. The first large, randomized, double-blind, placebo-controlled clinical trial using sildenafil in patients with pulmonary arterial hypertension was reported in 2005. As a result of this and other studies, sildenafil is now used to treat idiopathic pulmonary hypertension. Future studies are required to assess the potential use of other PDE5 antagonists and combination therapy on pulmonary hemodynamics, functional capacity, and long-term prognosis in the treatment of pulmonary arterial hypertension.
Current Sexual Health Reports – Springer Journals
Published: Nov 25, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.